Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Regulus Therapeutics Inc. (RGLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates"
06/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/12/2023 SC 13D/A Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc.
05/11/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates"
05/10/2023 SC 13G/A FEDERATED HERMES, INC. reports a 19.9% stake in REGULUS THERAPEUTICS, INC.
04/13/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Certificate of Designation of Preferences, Rights and Limitations of Class A-5 Convertible Preferred Stock",
"Securities Purchase Agreement, by and among the Company and the Purchasers",
"Regulus Therapeutics Announces $15 Million Private Placement of Equity"
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates"
02/01/2023 SC 13G/A FEDERATED HERMES, INC. reports a 17.2% stake in REGULUS THERAPEUTICS, INC.
01/31/2023 SC 13G/A VICTORY CAPITAL MANAGEMENT INC reports a 5% stake in Regulus Therapeutics Inc.
01/11/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
01/06/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
12/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
10/11/2022 SC 13G FMR LLC reports a 15% stake in REGULUS THERAPEUTICS INC
08/11/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/11/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/11/2022 8-K Quarterly results
07/15/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
06/13/2022 8-K Quarterly results
05/16/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
04/27/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/15/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/10/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy